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“Abstract.” Heterocycles containing phthalazine moiety have been a subject of 
great interest. They have been reported by their anticonvulsant, cardiotonic and 
vasorelaxant activities. Despite the number of available methods for their synthesis, the 
development of new synthetic methods for the efficient preparation of heterocycles 
containing phthalazine fragment is an interesting challenge. Therefore, we have 
synthesized new phthalazine-1,4-dione derivatives by introduction of halogenoalkyl 
substituents on the NH-nucleophilic groups. The described synthetic route will allow us 
to condense a nitrogen heterocyclic ring on the phthalazinone moiety and obtain a new 
tricyclic scaffold with promising pharmacological properties. 
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Introduction 
The discovery of the first naturally occurring pyridazine derivative (pyridazomycin) 
meant a milestone in the recognition of the potential of the 1,2-diazine core as a 
valuable unit in medicinal chemistry.
1
 In particular, 3 oxo derivatives [pyridazin-3(2H)-
one scaffold] have shown a wide range of biological actions, specially on targets that 
play a key role in cardiovascular diseases.
2
 Hydralazine is also a hydrazine derivative 
used clinically as a vasodilator and antihypertensive agent.
3
 More recently, several 4-
substituted phthalazin-1-one have been reported because they afforded total relaxation 
on isolated rat aorta rings pre-contracted with phenylephrine at micromolar 
concentration.
4
 Azelastine is a relevant member of this family of compounds which has 




With these precedents and with the aim of preparing new derivatives with potential 
pharmacological activity, we have synthesized new phthalazinone derivatives in which, 
4-substituent of azelastine is replaced by a carbonyl group.
6
 Additionally halogenoalkyl 
substituents with different chain length have been introduced on the NH-nucleophilic 
groups.
7 




The described derivatives bearing N-alkylazide groups will allow us to condense a 
nitrogen heterocyclic ring on the phthalazinone moiety obtaining a new tricyclic 















Results and discussion 
8-Chloro-2-methyl-2,3-dihydrophthalazine-1,4-dione (1a) and 5-chloro-2-methyl-
2,3-dihydrophthalazine-1,4-dione (1b) were obtained from reaction of 4-chlorophtalic 
anhydride with methylhydrazine and subsequent separation by HPLC resulting the 
isomer 1a as majority compound of the mixture. 
Compounds 2b, 2c and 2d were obtained by N- alkylation of the phthalazine-1,4-
dione derivatives using dihalogenoalkyl groups with different length chains after 
removing hydrogen atom of NH group in basic conditions. However, 2-(2-bromo-
ethyl)-8-chloro-2-methyl-2,3-dihydrophthalazine-1,4-dione] (2a) resulted a very 
unstable derivative and it was not isolated following the described procedure.  
Finally, by nucleophilic substitution of the halogen groups, were obtained the azide 
derivatives 3a, 3b and 3c. 
All the new derivatives were obtained in good yields. 
 
Chemistry 
The phthalazine-1,4-dione derivatives were efficiently synthesized according to the 
synthetic protocol outlined in Scheme 1. 
Preparation of phthalzine-1,4-diones 1a and 1b was performed using microwaves 
assisted Gabriel synthesis by reaction of 4-chlorophtalic anhydride and 
methylhydrazine.
6
 The resulting compounds were separated by HPLC.  
Phthalzine-1,4-diones, 1a and 1b reacted with either 1,3-dibromopropane or 1,2-
dibromoethane, using K2CO3 in acetone affording the compounds 2b, 2d and 2c 
respectively.
7
 However, because of its instability, it was not possible to isolate the 
compound 2a. 
Finally the reaction of N, N-dialkyl-5-chloro-2,3-dihydro-phthalazine-1,4-dione 
derivatives 2b, 2c and 2d were done to react with sodium azide and NaI in DMSO to 















1a: R1= CH3; R2= H









































Reagents and Conditions: a) CH3NHNH2, MW; b) Br(CH2)nBr, K2CO3, (CH3)2CO, reflux; 




Series of new N, N-dialkylphthalazine-1,4-dione derivatives were synthesized in two 
or three steps starting from 4-chlorophthalic anhydride. This versatile and efficient 
route, let to afford huge family of compounds that can be considered a useful 
intermediates for the preparation of new tricyclic compounds.  
 
Experimental section 
Preparation of 8-chloro-2-methyl-2,3-dihydrophthalazine-1,4-dione (1a) and 5-
chloro-2-methyl-2,3-dihydrophthalazine-1,4-dione (1b). 
The 4-chlorophtalic anhydride (5.48 mmol), methyl-hidrazine 98% (6.025mmol) and 
montmorillonite KSF clay (5 g) were mixed and grinded properly in a mortar, and 
placed in a clean and dry beaker. The reaction mixture was first preheated in a 
microwave oven for 15 minutes in periods of 1 minute each one (power 350 W) and the 
heating continued for 1 minute (power 450 W) and other minute (600 W) for 
completion of the reaction. The reaction mixture was cooled to the room temperature 
and the resulting product extracted with CH2Cl2/MeOH (9/1) (4 X 25 mL). The 
montmorillonite KSF clay was filtered off and the solvent removed by rotary. 
Compounds 1a and 1b were separated by HPLC (CHCl3/iPrOH 2%). 
Compound (1a). Yield: 62%. Melting point: 233ºC 
Compound (1b). Yield: 34%. Melting point: 238ºC 
 
Preparation of 2-(3-Bromopropyl)-8-chloro-3-methyl-2,3-dihydrophthalazine-1,4-
dione (2b) and 2-(3-Bromopropyl)-5-chloro-3-methyl-2,3-dihydrophthalazine-1,4-
dione (2d). 
Compound (1a) or (1b) (2.37 mmol) and K2CO3 (7.12 mmol) were suspended en 
acetone (100mL). 1, 4-Dibromopropane (7.12 mmol) was added to the suspension and 
then the reaction mixture was stirred at room temperature for 24 hours. The K2CO3 was 
filtered off and the solvent removed by rotary. The crude product was purified by 
chromatography column (hexane/ ethylacetate 9/1 and 85/15). 
Compound (2b). Yield: 85%. Melting Point: 115ºC  




Compound (1a) (2.37 mmol) and K2CO3 (7.12 mmol) were suspended en acetone 
(100mL). 1, 4-Dibromoethane (7.12 mmol) was added to the suspension and the 
reaction mixture was stirred at room temperature for 24 hours. The K2CO3 was filtered 
off and the solvent removed by rotary. The crude product was purified by column 
chromatography (hexane/ ethylacetate 9/1 and 85/15) obtaining 2c. Yield: 17%. Melting 
Point: 110ºC. 
Preparation of 2-(3-Azidopropyl)-8-chloro-3-methyl-2,3-dihydrophthalazine-1,4-
dione (3a) and 2-(3-Azidopropyl)-5-chloro-3-methyl-2,3-dihydrophthalazine-1,4-
dione (3c) 
Compound (2b) or (2d), sodium azide (3.48 mmol) and NaI (0.174 mmol) were 
suspended in DMSO. The reaction mixture was heated under reflux for 24h. The solvent 
was evaporated under vacuum and the crude product was purified by HPLC 
(MeOH/H2O (9/1). 
Compound (3a). Yield: 70%. Melting Point: 61ºC 
Compound (3c). Yield: 66%. Melting Point: 73ºC 
Preparation of 2-(2-Azidoethyl)-5-chloro-3-methyl-2,3-dihydrophthalazine-1,4-
dione. (3b) 
Compound (2c) (1.57 mmol), sodium azide (3.48 mmol) and NaI (0.174 mmol) were 
suspended in DMSO. The reaction mixture was heated under reflux for 24h. The solvent 
was evaporated under vacuum and the crude product was purified by HPLC 




 Grok, R.; Chen, Y.; Zeeck, A.; Chen, Z.; Zähner, H.; Mischnick-lübbecke, P.; 
Köning, W. A. J. Antibiot. 41, 1988, 595. 
2
 Meyers, C.; Yáñez, M.; Elmaatogui, A.; Verhelst, T.; Coelho, A.; Fraiz, N.; 
Lemiére, G. L. F.; García-Mera, X.; Laguna, R.; Cano, E.; Maes, B. U. W.; Sotelo, E. 
Bioorg. Med. Chem. Lett. 18, 2008, 793. 
3
 Campos-Toimil, M.; Verde, I.; Gil-Longo J., Fdez-Grandal, D.; Orallo F. Can. J. 
Pharmac. 72 (suppl 1), 1994, 183. 
4
 del Olmo, E.; Barboza, B.; Ybarra M. I.; López Pérez, J. L.; Carrón, R.; Sevilla, M. 
A.; Boselli, C.; San Feliciano, A. Bioorg. Med. Chem. Lett. 16, 2006, 2786. 
5
 Lee, H.; Ohja, Y.; Doupnik, C. A.; Sperelakis, N. Eur. J. Pharmacol. 187, 1990, 67. 
6
 Viña, D.; del Olmo, E.; López-Pérez, J. L.; San Feliciano, A. Tetrahedron, 65, 
2009, 1574.  
7 
 Hou, D.;  Cheng, H. Y. and Wang, E.C. J. Org. Chem. 69, 2004, 6094. 
8
 Scriven, E.; Turnbull, K. Chem.Rev., 88, 1998, 299. 
9
 Lambert, P.H.; Vaultier, M.; Carrié, R. J. Org. Chem. 50, 1985, 5352. 
10
 Qian, J.; Xu, Y., Qian, X.; Zhang, S. Chemphyschem, 9, 2008, 1891. 
 
